Skip to content
Recall Observatory FDA recall evidence

Device product

RANDOX Total Bilirubin.

Z-0501-2024

October 11, 2023

Class II

Product summary

Firm
Randox Laboratories Ltd.
Event
Event 93387
Status
Ongoing
Classification
Class II
Quantity
1644 units
Official record key
device-enforcement:Z-0501-2024

Official wording

Reason: Randox has had reports of elevated patient results using Plasma (lithium heparin) samples with Total Bilirubin reagent (TBil) Vanadate Oxidation Method.

Code information: Catalog No. BR8377, BR9766, & BR4061; GTIN: 05055273214772, 05055273208337, & 05055273214765; All Batches.

Distribution pattern: US Nationwide distribution in the states of AR, GA, NC, TN, & PR.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Randox has had reports of elevated patient results using Plasma (lithium heparin) samples with Total Bilirubin reagent (TBil) Vanadate Oxidation Method.